Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

INSULIN - ANVISA Registration 10350840457

Access comprehensive regulatory information for INSULIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840457 and manufactured by BODITECH MED INC.. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10350840457
Registration Details
ANVISA Registration Number: 10350840457
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Famรญlia AFIAS Insulin
Risk Class II

Registration Details

10350840457

25351228459202401

02220795000179

Company Information

BODITECH MED INC.
South Korea
PT: CORร‰IA DO SUL

Dates and Status

May 13, 2024

VIGENTE

09/18/2025 19:00:01